258 related articles for article (PubMed ID: 30012638)
1. Evaluation of Adenylate Cyclase Toxoid Antigen in Acellular Pertussis Vaccines by Using a Bordetella pertussis Challenge Model in Mice.
Boehm DT; Hall JM; Wong TY; DiVenere AM; Sen-Kilic E; Bevere JR; Bradford SD; Blackwood CB; Elkins CM; DeRoos KA; Gray MC; Cooper CG; Varney ME; Maynard JA; Hewlett EL; Barbier M; Damron FH
Infect Immun; 2018 Oct; 86(10):. PubMed ID: 30012638
[No Abstract] [Full Text] [Related]
2. Effect of priming with diphtheria and tetanus toxoids combined with whole-cell pertussis vaccine or with acellular pertussis vaccine on the safety and immunogenicity of a booster dose of an acellular pertussis vaccine containing a genetically inactivated pertussis toxin in fifteen- to twenty-one-month-old children. Italian Multicenter Group for the Study of Recombinant Acellular Pertussis Vaccine.
Podda A; Bona G; Canciani G; Pistilli AM; Contu B; Furlan R; Meloni T; Stramare D; Titone L; Rappuoli R
J Pediatr; 1995 Aug; 127(2):238-43. PubMed ID: 7636648
[TBL] [Abstract][Full Text] [Related]
3. A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children.
Pichichero ME; Deloria MA; Rennels MB; Anderson EL; Edwards KM; Decker MD; Englund JA; Steinhoff MC; Deforest A; Meade BD
Pediatrics; 1997 Nov; 100(5):772-88. PubMed ID: 9346976
[TBL] [Abstract][Full Text] [Related]
4. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.
Salmaso S; Mastrantonio P; Tozzi AE; Stefanelli P; Anemona A; Ciofi degli Atti ML; Giammanco A;
Pediatrics; 2001 Nov; 108(5):E81. PubMed ID: 11694665
[TBL] [Abstract][Full Text] [Related]
5. Blockade of the Adenylate Cyclase Toxin Synergizes with Opsonizing Antibodies to Protect Mice against Bordetella pertussis.
DiVenere AM; Amengor D; Silva RP; Goldsmith JA; McLellan JS; Maynard JA
mBio; 2022 Aug; 13(4):e0152722. PubMed ID: 35920558
[No Abstract] [Full Text] [Related]
6. Protective role of adenylate cyclase in the context of a live pertussis vaccine candidate.
Lim A; Ng JK; Locht C; Alonso S
Microbes Infect; 2014 Jan; 16(1):51-60. PubMed ID: 24140230
[TBL] [Abstract][Full Text] [Related]
7. The Bordetella adenylate cyclase repeat-in-toxin (RTX) domain is immunodominant and elicits neutralizing antibodies.
Wang X; Gray MC; Hewlett EL; Maynard JA
J Biol Chem; 2015 Feb; 290(6):3576-91. PubMed ID: 25505186
[TBL] [Abstract][Full Text] [Related]
8. Different T cell memory in preadolescents after whole-cell or acellular pertussis vaccination.
Smits K; Pottier G; Smet J; Dirix V; Vermeulen F; De Schutter I; Carollo M; Locht C; Ausiello CM; Mascart F
Vaccine; 2013 Dec; 32(1):111-8. PubMed ID: 24176499
[TBL] [Abstract][Full Text] [Related]
9. Intranasal Immunization with Acellular Pertussis Vaccines Results in Long-Term Immunity to Bordetella pertussis in Mice.
Wolf MA; Boehm DT; DeJong MA; Wong TY; Sen-Kilic E; Hall JM; Blackwood CB; Weaver KL; Kelly CO; Kisamore CA; Bitzer GJ; Bevere JR; Barbier M; Damron FH
Infect Immun; 2021 Feb; 89(3):. PubMed ID: 33318136
[No Abstract] [Full Text] [Related]
10. Assessment of safety and efficacy against Bordetella pertussis of a new tetanus-reduced dose diphtheria-acellular pertussis vaccine in a murine model.
Kwon HJ; Han SB; Kim BR; Kang KR; Huh DH; Choi GS; Ahn DH; Kang JH
BMC Infect Dis; 2017 Apr; 17(1):247. PubMed ID: 28376777
[TBL] [Abstract][Full Text] [Related]
11. [Acellular pertussis vaccine].
Wiedermann G; Ambrosch F; Vanura H
Wien Med Wochenschr; 1991; 141(12):270-2. PubMed ID: 1949820
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and Safety of Monovalent Acellular Pertussis Vaccine at Birth: A Randomized Clinical Trial.
Wood N; Nolan T; Marshall H; Richmond P; Gibbs E; Perrett K; McIntyre P
JAMA Pediatr; 2018 Nov; 172(11):1045-1052. PubMed ID: 30208475
[TBL] [Abstract][Full Text] [Related]
13. Proteomics of Bordetella pertussis whole-cell and acellular vaccines.
Möller J; Kraner ME; Burkovski A
BMC Res Notes; 2019 Jun; 12(1):329. PubMed ID: 31182148
[TBL] [Abstract][Full Text] [Related]
14. Reactivating Immunity Primed by Acellular Pertussis Vaccines in the Absence of Circulating Antibodies: Enhanced Bacterial Control by TLR9 Rather Than TLR4 Agonist-Including Formulation.
Auderset F; Ballester M; Mastelic-Gavillet B; Fontannaz P; Chabaud-Riou M; Reveneau N; Garinot M; Mistretta N; Liu Y; Lambert PH; Ochs M; Siegrist CA
Front Immunol; 2019; 10():1520. PubMed ID: 31333656
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of experimental and commercial pertussis vaccines in the elimination of Bordetella pertussis isolates with different genetic profiles in murine model.
Prygiel M; Mosiej E; Wdowiak K; Górska P; Polak M; Lis K; Krysztopa-Grzybowska K; Zasada AA
Med Microbiol Immunol; 2021 Dec; 210(5-6):251-262. PubMed ID: 34338880
[TBL] [Abstract][Full Text] [Related]
16. Pertussis vaccine: a critique.
Robbins JB; Schneerson R; Keith JM; Miller MA; Kubler-Kielb J; Trollfors B
Pediatr Infect Dis J; 2009 Mar; 28(3):237-41. PubMed ID: 19165133
[TBL] [Abstract][Full Text] [Related]
17. Acellular vaccines induce cell-mediated immunity to Bordetella pertussis antigens in infants undergoing primary vaccination against pertussis.
Ausiello CM; Urbani F; La Sala A; Lande R; Piscitelli A; Cassone A
Dev Biol Stand; 1997; 89():315-20. PubMed ID: 9272365
[TBL] [Abstract][Full Text] [Related]
18. Adjuvanticity of native and detoxified adenylate cyclase toxin of Bordetella pertussis towards co-administered antigens.
Macdonald-Fyall J; Xing D; Corbel M; Baillie S; Parton R; Coote J
Vaccine; 2004 Oct; 22(31-32):4270-81. PubMed ID: 15474718
[TBL] [Abstract][Full Text] [Related]
19. Immunization with whole cell but not acellular pertussis vaccines primes CD4 T
Wilk MM; Borkner L; Misiak A; Curham L; Allen AC; Mills KHG
Emerg Microbes Infect; 2019; 8(1):169-185. PubMed ID: 30866771
[TBL] [Abstract][Full Text] [Related]
20. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group.
Greco D; Salmaso S; Mastrantonio P; Giuliano M; Tozzi AE; Anemona A; Ciofi degli Atti ML; Giammanco A; Panei P; Blackwelder WC; Klein DL; Wassilak SG
N Engl J Med; 1996 Feb; 334(6):341-8. PubMed ID: 8538704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
